BioNTech SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,741	7,675	9,762	11,664	13,875	1,693
Short-Term Investments	5,038	7,202	7,022	4,885	189.4	381.6
Cash & Short-Term Investments	14,779	14,877	16,784	16,549	14,065	2,074
Cash Growth	5.29%	-11.36%	1.42%	17.66%	578.04%	53.95%
Accounts Receivable	163.9	924.2	1,464	2,156	7,146	12,382
Other Receivables	10.4	8.1	10	4.9	-	-
Total Trade Receivables	174.3	932.3	1,474	2,161	7,146	12,382
Inventory	100.6	110.7	283.3	357.7	439.6	502.5
Other Current Assets	243.6	226.4	262.7	460	272.3	113.8
Total Current Assets	15,297	16,147	18,804	19,527	21,922	15,072
Net Property, Plant & Equipment	1,218	1,291	1,183	971.6	821.1	520.4
Other Intangible Assets	1,422	1,606	790.4	804.1	158.5	202.4
Goodwill	373.3	367.9	380.6	362.5	61.2	-
Long-Term Investments	2,006	2,554	1,254	1,176	80.2	21.3
Other Long-Term Assets	26	22.8	117.8	164.7	236.1	14.4
Total Assets	20,343	21,989	22,530	23,006	23,279	15,831
Accounts Payable	646.7	534.9	426.7	354	204.1	160
Accrued Expenses	234.9	145.3	144.8	269.3	367.2	110.2
Current Portion of Leases	57.2	52.2	39.5	28.1	36	129.9
Unearned Revenue	742.5	754.9	294.9	353.3	101.5	276.1
Other Current Liabilities	267.9	655	1,617	1,066	2,242	2,805
Total Current Liabilities	1,949	2,142	2,523	2,071	2,951	3,482
Long-Term Leases	258.9	215.2	214.7	191	176.2	171.6
Other Long-Term Liabilities	377	406.9	380.7	498.9	96.7	283.9
Total Long-Term Liabilities	635.9	622.1	595.4	689.9	272.9	455.5
Total Liabilities	2,585	2,764	3,119	2,760	3,224	3,937
Common Stock	259	259	248.6	248.6	248.6	246.3
Treasury Stock	-7.8	-7.7	-8.6	-10.8	-5.3	-3.8
Additional Paid-in Capital	2,339	2,473	1,399	1,229	1,828	1,674
Accumulated Other Comprehensive Income	-1,442	-1,462	-1,326	-984.6	-848.9	93.9
Retained Earnings	16,609	17,962	19,098	19,763	18,833	9,883
Shareholders' Equity	17,758	19,224	19,411	20,246	20,056	11,894
Total Liabilities & Equity	20,343	21,989	22,530	23,006	23,279	15,831
Total Debt	316.1	267.4	254.2	219.1	212.2	301.5
Net Cash (Debt)	14,463	14,610	16,529	16,330	13,852	1,773
Net Cash Growth	5.05%	-11.61%	1.22%	17.89%	681.38%	60.10%
Net Cash Per Share	57.55	60.45	68.76	67.28	55.45	6.83
Book Value	17,758	19,224	19,411	20,246	20,056	11,894
Book Value Per Share	70.66	79.54	80.75	83.42	80.29	45.80
Tangible Book Value	15,963	17,250	18,240	19,079	19,836	11,691
Tangible Book Value Per Share	63.51	71.37	75.87	78.61	79.41	45.02